Morpheus - Global Registry V1.0.0

• Research type

  Research Study

• Full title

  Morpheus-Global Registry: A prospective, single-arm, multi-centre, observational, real world registry to evaluate safety and performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for very long coronary lesions.

• IRAS ID

  215550

• Contact name

  Azfar Zaman

• Contact email

  Azfar.Zaman@nuth.nhs.uk

• Sponsor organisation

  Meril Life Sciences Pvt Ltd

• Clinicaltrials.gov Identifier

  NCT02901353

• Duration of Study in the UK

  3 years, 3 months, 30 days

• Research summary

  Morpheus-Global Registry: A prospective, single-arm, multi-centre, observational, real world registry to evaluate safety and performance of the BioMime™ Morph Sirolimus Eluting Coronary Stent System for very long coronary lesions.
  This study will be conducted for post marketing follow up data collection of Coronary artery disease patients who have received treatment for BioMime Morph CE approved Device as a part of their standard therapy. The informed consent process will be performed either before the PCI or after the subject is already treated. No interventional or laboratory follow up will be performed.

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  17/NE/0333

• Date of REC Opinion

  16 Jan 2018

• REC opinion

  Further Information Favourable Opinion